top of page
Valuations
Investing in life sciences is unique - long-term returns, environmental uncertainty and development risks require a different approach to establishing arbitrage opportunities, understanding market risks and valuing assets
We help you understand which markets to target, how much your technology is worth, assess and mitigate environmental risks and how to enhance the value of your portfolio
We also work with investors - we assist in validating your financial models through critical assessments and provide commercial due diligence for your investments, giving you an external perspective on the opportunities and risks with a potential investment
Valuation Services:
-
Holistic market assessments and sizing
-
Asset valuations and NPV analysis
-
Risk assessment modelling
-
Risk-adjusted forecasting and valuations
-
Identification of value drivers
-
Portfolio review and valuation
-
Critical assessments and commercial due diligence
Case Studies
Private Equity Fund
Pre-Deal Critical Assessment
A European Private Equity firm engaged us to perform a critical assessment of their valuation model and assumptions prior to completing a sizeable investment into a Neurology Start-up
With time of the essence, we provided expert advice on revenue and OPEX assumptions within tight timelines to allow our client to successfully close the investment
Private Investor
Company Valuation
A private investor and founder of an early-stage biotech engaged us to conduct a valuation of his business, which included two assets in pre-clinical and phase I
We provided a comprehensive analysis and financial model to identify key value inflection points of the individual indications as well as the firm as a whole
bottom of page